Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma

[1]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[2]  Zhangren Yan,et al.  Progress in experimental research on SPRED protein family , 2020, The Journal of international medical research.

[3]  Nicholas B. Griner,et al.  Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes. , 2020, Nature Genetics.

[4]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[5]  Chromatin Remodeling , 2020, Definitions.

[6]  Dazhou Li,et al.  PRKDC is a prognostic marker for poor survival in gastric cancer patients and regulates DNA damage response. , 2019, Pathology, research and practice.

[7]  Cigall Kadoch,et al.  Chromatin regulatory mechanisms and therapeutic opportunities in cancer , 2019, Nature Cell Biology.

[8]  P. Cohen,et al.  Cervical cancer , 2019, The Lancet.

[9]  X. Yi,et al.  Comprehensive genomic variation profiling of cervical intraepithelial neoplasia and cervical cancer identifies potential targets for cervical cancer early warning , 2018, Journal of Medical Genetics.

[10]  A. Yan,et al.  MicroRNA-562 negatively regulated c-MET/AKT pathway in the growth of glioblastoma cells , 2018, OncoTargets and therapy.

[11]  D. Aoki,et al.  Cancer of the cervix uteri , 2018, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[12]  Ville Mustonen,et al.  The repertoire of mutational signatures in human cancer , 2018, Nature.

[13]  Michael T. Zimmermann,et al.  Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas , 2018, Cell reports.

[14]  A. I. Ojesina,et al.  Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study , 2017, American journal of obstetrics and gynecology.

[15]  Gang Sun,et al.  PRKDC regulates chemosensitivity and is a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients. , 2017, Oncology reports.

[16]  Steven J. M. Jones,et al.  Integrated genomic and molecular characterization of cervical cancer , 2017, Nature.

[17]  S. Knapp,et al.  Epigenomic regulation of oncogenesis by chromatin remodeling , 2016, Oncogene.

[18]  Peng Zhang,et al.  Identification of PRKDC (Protein Kinase, DNA-Activated, Catalytic Polypeptide) as an essential gene for colorectal cancer (CRCs) cells. , 2016, Gene.

[19]  Feng Li,et al.  Diagnosis and Prognostic Significance of c-Met in Cervical Cancer: A Meta-Analysis , 2016, Disease markers.

[20]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[21]  G. Getz,et al.  Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women , 2015, International journal of cancer.

[22]  M. Yeager,et al.  Genome Analysis of Latin American Cervical Cancer: Frequent Activation of the PIK3CA Pathway , 2015, Clinical Cancer Research.

[23]  F. Valderrama,et al.  ERM proteins in cancer progression , 2015, Journal of Cell Science.

[24]  E. Golomazou,et al.  Molecular cloning of four glutathione peroxidase (GPx) homologs and expression analysis during stress exposure of the marine teleost Sparus aurata. , 2014, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[25]  F. Valderrama,et al.  ERM proteins in cancer progression , 2014, Journal of Cell Science.

[26]  Trevor J Pugh,et al.  Landscape of genomic alterations in cervical carcinomas , 2013, Nature.

[27]  Nikhil Wagle,et al.  Oncogenic mutations in cervical cancer , 2013, Cancer.

[28]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[29]  N. A. Temiz,et al.  Evidence for APOBEC3B mutagenesis in multiple human cancers , 2013, Nature Genetics.

[30]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[31]  G. Thomas,et al.  Cancer of the cervix uteri , 2012, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[32]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[33]  H. Schumny,et al.  Next Generation , 2020 .

[34]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[35]  Liwei Wang,et al.  The Fas–FADD death domain complex structure reveals the basis of DISC assembly and disease mutations , 2010, Nature Structural &Molecular Biology.

[36]  M. Gessler,et al.  Loss of Heterozygosity at 2q37 in Sporadic Wilms' Tumor: Putative Role for miR-562 , 2009, Clinical Cancer Research.

[37]  F. Schmidt.  Meta-Analysis , 2008 .

[38]  E. Lander,et al.  Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.

[39]  H. Kurita,et al.  Clinical Significance of Cellular Distribution of Moesin in Patients with Oral Squamous Cell Carcinoma , 2004, Clinical Cancer Research.

[40]  W. Small,et al.  c-Met Overexpression in Cervical Cancer, a Prognostic Factor and a Potential Molecular Therapeutic Target , 2017, American journal of clinical oncology.

[41]  A. V. D. Van Der Zee,et al.  Breaking the DNA damage response to improve cervical cancer treatment. , 2016, Cancer treatment reviews.

[42]  J. Mesirov,et al.  The Molecular Signatures Database (MSigDB) hallmark gene set collection. , 2015, Cell systems.

[43]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .

[44]  Trevor J Pugh,et al.  Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .

[45]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[46]  L. G. Koss,et al.  Cervical Cancer , 1981, Current Topics in Pathology.